The Alliance of Specialty Medicine wrote a letter to Rep. Morgan Griffith (R-VA) thanking him for the introduction of H.R. 1703, the Medical Products Communications Act.  The legislation would set clear parameters on what constitutes a “scientific exchange” by which a manufacturer of a medicine or a medical device could share data related to that drug or device′s off-label use.  H.R. 1703 pushes back on the Food and Drug Administration′s currently negative characterization of off-label and strikes the right balance on data sharing in order to benefit patients.


Click here to read the letter.   

The Alliance Staff

Author The Alliance Staff

More posts by The Alliance Staff

Leave a Reply